Literature DB >> 6743063

Intracranial pressure monitoring in comatose patients with cerebral hemorrhage.

A H Ropper, R B King.   

Abstract

Intracranial pressure (ICP) was measured continuously in ten consecutive comatose patients with intracerebral hemorrhage. Eight hemorrhages were ganglionic, one was thalamic, and one was lobar. The ICP at the time of insertion of the monitoring device was below 20 mm Hg in four patients, 20 to 30 mm Hg in four, and above 30 mm Hg in two. Of the seven patients whose ICP remained above 20 mm Hg despite aggressive medical therapy, three had the clot removed surgically and all three survived, although one died of sepsis a month later. The remaining four patients with uncontrolled ICP all died of the syndrome of brain death. Of tht three patients whose ICP was persistently below 20 mm Hg, one survived and two subsequently died of sepsis after improving neurologically for the first week. Intracranial pressure monitoring did not cause any morbidity. Raised ICP is related to mortality in comatose patients with cerebral hemorrhage, and ICP monitoring may be useful in guiding therapy, especially the timing and selection of patients for surgery.

Entities:  

Mesh:

Year:  1984        PMID: 6743063     DOI: 10.1001/archneur.1984.04050180047016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhage.

Authors:  Fuyou Guo; Ya Hua; Jinhu Wang; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

Review 2.  Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage.

Authors:  Daniel Agustin Godoy; Gustavo Rene Piñero; Patricia Koller; Luca Masotti; Mario Di Napoli
Journal:  World J Crit Care Med       Date:  2015-08-04

3.  Neurological outcome after a severe herpes simplex encephalitis treated with acyclovir and beta-interferon. Time course of intracranial pressure.

Authors:  A Schmidt; D Bunjes; J Friedrich; W Koenig; T Eggeling; V Hombach
Journal:  Klin Wochenschr       Date:  1990-03-05

Review 4.  Intracerebral hemorrhage: pathophysiology and therapy.

Authors:  Guohua Xi; Matthew E Fewel; Ya Hua; B Gregory Thompson; Julian T Hoff; Richard F Keep
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 5.  Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?

Authors:  Hideki Matsuoka; Rikuzo Hamada
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Characteristics and sequelae of intracranial hypertension after intracerebral hemorrhage.

Authors:  Hooman Kamel; J Claude Hemphill
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 7.  Progress in translational research on intracerebral hemorrhage: is there an end in sight?

Authors:  Guohua Xi; Jennifer Strahle; Ya Hua; Richard F Keep
Journal:  Prog Neurobiol       Date:  2013-10-16       Impact factor: 11.685

8.  Intracranial Hypertension After Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis of Prevalence and Mortality Rate.

Authors:  Daniel Agustín Godoy; Rafael A Núñez-Patiño; Andres Zorrilla-Vaca; Wendy C Ziai; J Claude Hemphill
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

9.  Chinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study.

Authors:  Chun-Chung Chen; Han-Chung Lee; Ju-Hsin Chang; Shuang-Shuang Chen; Tsai-Chung Li; Chang-Hai Tsai; Der-Yang Cho; Ching-Liang Hsieh
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-12       Impact factor: 2.629

10.  Detection of cerebral hemorrhage in rabbits by time-difference magnetic inductive phase shift spectroscopy.

Authors:  Wencai Pan; Qingguang Yan; Mingxin Qin; Gui Jin; Jian Sun; Xu Ning; Wei Zhuang; Bin Peng; Gen Li
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.